federal_register: 2016-31144
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-31144 | Psychopharmacologic Drugs Advisory Committee; Notice of Meeting | Notice | The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Psychopharmacologic Drugs Advisory Committee. The general function of the committee is to provide advice and recommendations to the Agency on FDA's regulatory issues. The meeting will be open to the public. | 2016-12-27 | 2016 | 12 | https://www.federalregister.gov/documents/2016/12/27/2016-31144/psychopharmacologic-drugs-advisory-committee-notice-of-meeting | https://www.govinfo.gov/content/pkg/FR-2016-12-27/pdf/2016-31144.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Psychopharmacologic Drugs Advisory Committee. The general function of the committee is to provide advice and recommendations to the Agency on FDA's... |